2014
Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease
Bizzarro M, Gross I, Barbosa FT. Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease. 2014, 2014: cd005055. PMID: 24991723, PMCID: PMC10728583, DOI: 10.1002/14651858.cd005055.pub3.Peer-Reviewed Original ResearchConceptsMean pulmonary arterial pressurePulmonary hypertensive crisisCongenital heart diseaseLong-term mortalityPulmonary hypertensionHeart rateMethaemoglobin levelsNeurodevelopmental disabilitiesHospital stayArterial pressureNitric oxidePostoperative managementHeart diseaseEfficacy of iNOUse of iNOPulmonary arterial pressureSystemic blood pressureArterial oxygen tensionLength of stayMarkers of toxicityConventional managementHypertensive crisisPostoperative administrationPulmonary vasodilationSecondary outcomes
2005
Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease
Bizzarro M, Gross I. Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease. Cochrane Database Of Systematic Reviews 2005, cd005055. PMID: 16235391, DOI: 10.1002/14651858.cd005055.pub2.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsMean pulmonary arterial pressurePulmonary hypertensive crisisCongenital heart diseaseLong-term mortalityHeart diseasePulmonary hypertensionHeart rateHospital stayArterial pressureNitric oxidePostoperative managementMethodologic qualityMethaemoglobin levelsNeurodevelopmental disabilitiesEfficacy of iNOUse of iNOCochrane Central RegisterPulmonary arterial pressureSystemic blood pressureSubgroup of patientsHigh methodologic qualityMajority of outcomesMarkers of toxicityConventional managementHypertensive crisis